TY - JOUR
T1 - Inhibitory effect of the tea polyphenol, (-)-epigallocatechin gallate, on growth of cervical adenocarcinoma cell lines
AU - Noguchi, Mitsuyo
AU - Yokoyama, Masatoshi
AU - Watanabe, Sumiko
AU - Uchiyama, Michiko
AU - Nakao, Yoshifumi
AU - Hara, Kouichi
AU - Iwasaka, Tsuyoshi
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2006/3/28
Y1 - 2006/3/28
N2 - To investigate the effect of (-)-epigallocatechin gallate (EGCG) on cervical adenocarcinoma, we performed a cell proliferation assay. TRAP assay is used for telomerase activity, flow cytometry analysis and pKi-67 immunofluoroscein staining in cervical adenocarcinoma cell lines (OMC-4, TMCC-1). Our results showed that EGCG inhibited the proliferation assay, TRAP assay for telomerase activity of both cell lines. Although cell apoptosis was induced, we observed that the expression of pKi-67 was suppressed. Our data suggest that EGCG may be effective for the treatment of cervical adenocarcinoma. The mechanisms of the anti-tumor effects were revealed to be the inhibition of telomerase activity, the induction of apoptosis and cell cycle dysregulation.
AB - To investigate the effect of (-)-epigallocatechin gallate (EGCG) on cervical adenocarcinoma, we performed a cell proliferation assay. TRAP assay is used for telomerase activity, flow cytometry analysis and pKi-67 immunofluoroscein staining in cervical adenocarcinoma cell lines (OMC-4, TMCC-1). Our results showed that EGCG inhibited the proliferation assay, TRAP assay for telomerase activity of both cell lines. Although cell apoptosis was induced, we observed that the expression of pKi-67 was suppressed. Our data suggest that EGCG may be effective for the treatment of cervical adenocarcinoma. The mechanisms of the anti-tumor effects were revealed to be the inhibition of telomerase activity, the induction of apoptosis and cell cycle dysregulation.
UR - http://www.scopus.com/inward/record.url?scp=33645010140&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33645010140&partnerID=8YFLogxK
U2 - 10.1016/j.canlet.2005.03.053
DO - 10.1016/j.canlet.2005.03.053
M3 - Article
C2 - 15907368
AN - SCOPUS:33645010140
SN - 0304-3835
VL - 234
SP - 135
EP - 142
JO - Cancer Letters
JF - Cancer Letters
IS - 2
ER -